contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-vimians-interim-report-for-the-third-quarter-of-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm. 

Vimian Group

Vimian Group AB will publish its Interim Report for the third quarter of 2024 on Thursday, 24 October 2024, at 07.45 (CET). An audiocast will be organised for investors, analysts and media, ...

<div class="mfn-preamble"><p><strong>Vimian Group AB will publish its Interim Report for the third quarter of 2024 on Thursday, 24 October 2024, at 07.45 (CET). An audiocast will be organised for investors, analysts and media, on the same day at 09.00 (CET).</strong></p></div><div class="mfn-body"><p>CEO Patrik Eriksson and CFO Carl-Johan Zetterberg Boudrie, will present and comment on the report. The audiocast will be held in English and include a question-and-answer session.</p><p><strong>To attend the telephone conference:</strong><br>Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.<br><a rel="noopener" href="https://conference.financialhearings.com/teleconference/?id=50047234">https://conference.financialhearings.com/teleconference/?id=50047234</a></p><p><strong>To attend the webcast:</strong><br>Link: <a rel="noopener" href="https://ir.financialhearings.com/vimian-group-q3-report-2024">https://ir.financialhearings.com/vimian-group-q3-report-2024</a></p><p>Related presentation materials will be available on Vimian’s website (<a rel="noopener" href="https://vimian.com/investors/reports-and-presentations/">https://vimian.com/investors/reports-and-presentations/</a>) ahead of the telephone and web conference.</p></div><div class="mfn-footer mfn-contacts mfn-ddfb1f46825b"><p><strong class="mfn-heading-1">For further information, please contact:</strong></p><hr><p><strong>Maria Dahllöf Tullberg</strong><br>Head of IR, Communications &amp; Sustainability<br><a rel="noopener" href="mailto:maria.tullberg@vimian.com">maria.tullberg@vimian.com</a><br>+46 736 26 88 86</p></div><div class="mfn-footer mfn-about mfn-b6e2606a1fc5"><p><strong class="mfn-heading-1">About Vimian</strong></p><hr><p>Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 80 markets, has 1,100 employees and annual revenues of approximately EUR 330 million. For more information, please visit: <a rel="noopener" href="http://www.vimian.com.">www.vimian.com.</a> FNCA Sweden AB is appointed the Company’s Certified Adviser.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/c0738c9d-beb6-45a3-a3a1-c5612914c4c5/invitation-to-vimians-interim-report-for-the-third-quarter-of-2024.pdf" class="mfn-generated mfn-primary">Invitation to Vimian’s Interim Report for the third quarter of 2024</a></p></div>

Invitation to Vimian’s Interim Report for the third quarter of 2024

Return on capital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Drug development investment: Value creation through M&As and licensing agreements

Income statement

Amazon continues to grow in Sweden

Stay up to date with our newsletter